The psychological impact of a colorectal cancer diagnosis following a negative fecal occult blood test result

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 7, 2015, Pages 1032-1038

  Miles, Anne ^a   McClements, Paula L ^b   Steele, Robert J C ^c   Redeker, Claudia ^a   Sevdalis, Nick ^d,e   Wardle, Jane ^f  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b INFORMATION SERVICES DIVISION   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FALSE NEGATIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OCCULT BLOOD TEST; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; ANXIETY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; ETIOLOGY; FOLLOW UP; MIDDLE AGED; OCCULT BLOOD; PILOT STUDY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY;

AGED; ANXIETY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PILOT PROJECTS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84941764655     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0004     Document Type: Article

References (39)

1. World Health Organisation [Internet]. Cancer Fact sheet N-297. [updated 2015 Feb; cited 2014 June 11]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/.
2. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116:544-73.
3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 2008;103: 1541-9.
4. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357-67.
5. Parker MA, Robinson MHE, Scholefield JH, Hardcastle JD. Psychiatric morbidity and screening for colorectal cancer. J Med Screen 2002;9: 7-10.
6. Laing SS, Bogart A, Chubak J, Fuller S, Green BB. Psychological distress after a positive fecal occult blood test among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev 2014; 23:154-9.
7. Kapidzic A, Korfage IJ, van DL, van Roon AH, Reijerink JC, Zauber AG, et al. Quality of life in participants of a CRC screening program. Br J Cancer 2012;107:1295-301.
8. Wardle J, Williamson S, Sutton S, Biran A, Cuzick J, Atkin W. Psychological impact of bowel cancer screening. Health Psychol 2003;22:54-9.
9. Miles A, Wardle J, Atkin W. Receiving a screen-detected diagnosis of cancer: The experience of participants in the UK flexible sigmoidoscopy trial. Psychooncol 2003;12:784-802.
10. Petticrew MP, Sowden AJ, Lister-Sharp D, Wright K. False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess 2000;4:1-120.
11. Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, et al. Definition and taxonomy of interval colorectal cancers: A proposal for standardising nomenclature. Gut. 2014 Sep 5. [Epub ahead of print]doi:10.1136/gutjnl-2014-307992.
12. Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009;58:530-5.
13. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012;61:101-7.
14. Wilson RM. Screening for breast and cervical cancer as a common cause for litigation. A false negative result may be one of an irreducible minimumof errors. Br Med J 2000;320:1352-3.
15. Barratt A, Cockburn J, Furnival C, McBride A, Mallon L. Perceived sensitivity ofmammographic screening: Women's views on test accuracy and financial compensation for missed cancers. J Epidemiol Community Health 1999; 53:716-20.
16. Jepson RG, Hewison J, Thompson A, Weller D. Patient perspectives on information and choice in cancer screening: A qualitative study in the UK. Soc Sci Med 2007;65:890-9.
17. van Rijn AF, van Rossum LG, Deutekom M, Laheij RJ, Bossuyt PM, Fockens P, et al. Getting adequate information across to colorectal cancer screening subjects can be difficult. J Med Screen 2008;15:149-52.
18. Elder NC, Jacobson CJ, Zink T, Hasse L. How experiencing preventable medical problems changed patients' interactions with primary health care. Ann Fam Med 2005;3:537-44.
19. Hall S, Bobrow M, Marteau TM. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study. BMJ 2000;320:407-12.
20. Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988.
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in healthrelated quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582-92.
22. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371-83.
23. Simon AE, Wardle J. Socioeconomic disparities in psychosocial wellbeing in cancer patients. Eur J Cancer 2008;44:572-8.
24. Miles A, Voorwinden S, Chapman S, Wardle J. Psychologic predictors of cancer information avoidance among older adults: The role of cancer fear and fatalism. Cancer Epidemiol Biomarkers Prev 2008;17:1872-9.
25. Ward WL, Hahn EA, MoF, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACTC) quality of life instrument. Qual Life Res 1999;8:181-95.
26. Irwin M, Artin KH, Oxman MN. Screening for depression in the older adult: criterion validity of the 10-itemCenter for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 1999;159:1701-4.
27. Kahn JA, Bernstein DI, Rosenthal SL, Huang B, Kollar LM, Colyer JL, et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005;81:408-14.
28. National Statistics, Scotland. Scottish index of multiple deprivation [Internet]. Edinburgh: The Scottish Government; 2012 [cited 2014 Oct 9]. Available from: http://simd.scotland.gov.uk/publication-2012.
29. Acock AC. Working withmissing values. JMarriage Fam 2005;67:1012-28.
30. Lynch BM, Cerin E, Owen N, Aitken JF. Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors. Cancer Cause Control 2007; 18:735-42.
31. Bynum SA, Davis JL, Green BL, Katz RV. Unwillingness to participate in colorectal cancer screening: Examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. Am J Health Promot 2012;26:295-300.
32. Davis JL, Bynum SA, Katz RV, Buchanan K, Green BL. Sociodemographic differences in fears and mistrust contributing to unwillingness to participate in cancer screenings. J Health Care Poor Underserved 2012; 23:67-76.
33. Menon U, Szalacha L, Prabhughate A, Kue J. Correlates of colorectal cancer screening among SouthAsian immigrants in the United States. Cancer Nurs 2014;37:E19-E27.
34. Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010;17: 68-74.
35. Burgess CC, Ramirez AJ, Richards MA, Potts HWW. Does the method of detection of breast cancer affect subsequent psychiatric morbidity? Eur J Cancer 2002;38:1622-5.
36. Haddad P, Maguire P, Jones B. Does detection of breast cancer by screening affect subsequent psychiatric morbidity? Breast 1994;3:218-21.
37. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089-97.
38. Miles A, Waller J, Wardle J. Psychological consequences of cancer screening. In:Miller SM, Bowen DJ, Croyle RT, Rowland JH, editors. Handbook of cancer control and behavioral science. Washington, DC: American Psychological Association; 2009. p. 279-301.
39. Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012;61: 576-81.